These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20556807)

  • 21. Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.
    Brummitt RK; Nesta DP; Chang L; Kroetsch AM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2104-19. PubMed ID: 21213307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition.
    Hari SB; Lau H; Razinkov VI; Chen S; Latypov RF
    Biochemistry; 2010 Nov; 49(43):9328-38. PubMed ID: 20843079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The identification of free cysteine residues within antibodies and a potential role for free cysteine residues in covalent aggregation because of agitation stress.
    Huh JH; White AJ; Brych SR; Franey H; Matsumura M
    J Pharm Sci; 2013 Jun; 102(6):1701-1711. PubMed ID: 23559428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of weak/non-complement-binding HLA antibodies on C1q-binding.
    Hönger G; Amico P; Arnold ML; Spriewald BM; Schaub S
    HLA; 2017 Aug; 90(2):88-94. PubMed ID: 28585289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays.
    Navas A; Molina J; Agüera ML; Guler I; Jurado A; Rodríguez-Benot A; Alonso C; Solana R
    Front Immunol; 2019; 10():1712. PubMed ID: 31428086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a reduced disulfide bond on aggregation properties of the human IgG1 CH3 domain.
    Sakurai K; Nakahata R; Lee YH; Kardos J; Ikegami T; Goto Y
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1526-35. PubMed ID: 25748879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural Changes and Aggregation Mechanisms of Two Different Dimers of an IgG2 Monoclonal Antibody.
    Zhang J; Woods C; He F; Han M; Treuheit MJ; Volkin DB
    Biochemistry; 2018 Sep; 57(37):5466-5479. PubMed ID: 30141909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions.
    Yageta S; Lauer TM; Trout BL; Honda S
    Mol Pharm; 2015 May; 12(5):1443-55. PubMed ID: 25871775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid-induced aggregation propensity of nivolumab is dependent on the Fc.
    Liu B; Guo H; Xu J; Qin T; Xu L; Zhang J; Guo Q; Zhang D; Qian W; Li B; Dai J; Hou S; Guo Y; Wang H
    MAbs; 2016; 8(6):1107-17. PubMed ID: 27310175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Structural and functional characteristics of IgG1- and IgG2-antibody subclasses in the guinea pig. 2. Production and testing of specific antisera against IgG1 and IgG2-antibody subclasses and against Fc-, Fc'- and Fab-papain fragments of IgG2-antibodies in guinea pigs].
    Drössler K; Hädge D; Ambrosius H
    Acta Biol Med Ger; 1982; 41(4):393-400. PubMed ID: 7124257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Labile disulfide bonds and free thiol groups in human IgG. I. Assignment to IgG1 and IgG2 subclasses.
    Schauenstein E; Dachs F; Reiter M; Gombotz H; List W
    Int Arch Allergy Appl Immunol; 1986; 80(2):174-9. PubMed ID: 3710611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective protocol for the investigation of physicochemical and conformational stability and aggregation kinetics measurements of therapeutic IgG2 monoclonal antibody.
    Aboel Dahab A; El-Hag D
    J Immunol Methods; 2014 Mar; 405():154-66. PubMed ID: 24530566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A stable engineered human IgG3 antibody with decreased aggregation during antibody expression and low pH stress.
    Saito S; Namisaki H; Hiraishi K; Takahashi N; Iida S
    Protein Sci; 2019 May; 28(5):900-909. PubMed ID: 30834577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggregation and pH-temperature phase behavior for aggregates of an IgG2 antibody.
    Sahin E; Weiss WF; Kroetsch AM; King KR; Kessler RK; Das TK; Roberts CJ
    J Pharm Sci; 2012 May; 101(5):1678-87. PubMed ID: 22246657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates.
    Liu-Shin L; Fung A; Malhotra A; Ratnaswamy G
    MAbs; 2018; 10(4):583-595. PubMed ID: 29436897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis.
    Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R
    J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small-angle x-ray scattering screening complements conventional biophysical analysis: comparative structural and biophysical analysis of monoclonal antibodies IgG1, IgG2, and IgG4.
    Tian X; Langkilde AE; Thorolfsson M; Rasmussen HB; Vestergaard B
    J Pharm Sci; 2014 Jun; 103(6):1701-10. PubMed ID: 24700358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggregation-prone motifs in human immunoglobulin G.
    Chennamsetty N; Helk B; Voynov V; Kayser V; Trout BL
    J Mol Biol; 2009 Aug; 391(2):404-13. PubMed ID: 19527731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies.
    Sahin E; Grillo AO; Perkins MD; Roberts CJ
    J Pharm Sci; 2010 Dec; 99(12):4830-48. PubMed ID: 20821389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine.
    Aase A; Høiby EA; Michaelsen TE
    Scand J Immunol; 1998 Apr; 47(4):388-96. PubMed ID: 9600322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.